The Case for Greater Investment in VTE Research – JTH
Journal of Thrombosis and Haemostasis (JTH) shared a post on LinkedIn about a recent article by Ryan Coute et al, adding:
“National Institutes of Health Funding for Venous Thromboembolism Research.
Despite VTE causing approximately 100,000 annual US deaths, NIH funding per death remains critically disproportionate at 639 dollars for VTE compared to 2,765 dollars for heart disease and 2,724 dollars for stroke, highlighting a significant research investment gap that urgently needs to be addressed.”
Title: National Institutes of Health funding for venous thromboembolism research
Authors: Ryan A. Coute, Jake Toy, Kameshwari Soundararajan, Benjamin von Schweinitz, Patrick J. Siler, Ryan C. Godwin, Ryan L. Melvin
Read the Full Article on Journal of Thrombosis and Haemostasis.
Stay updated on all scientific advances with Hemostasis Today.
-
May 27, 2026, 17:51Nita Radhakrishnan: Post Graduate Institute of Child Health Receives WFH Data Quality Certification for Excellence
-
May 27, 2026, 17:51Fiona Robinson: What exactly Are Rebalancing Agents for Bleeding Aisorders?
-
May 27, 2026, 17:14Khurram Nasir: Can Earlier LDL-C Lowering Change the Trajectory of Cardiovascular Disease?
-
May 27, 2026, 17:09Yvonne Jongejan: Allele-Selective Silencing Therapy for VWD and Thrombotic Disorders
-
May 27, 2026, 16:58Catherine Moran: Important Step Forward as 1st WHO Resolution on Stroke Gets Adopted at WHA79
-
May 27, 2026, 16:08Heghine Khachatryan: Thrombosis in Oncology Remains a Major Healthcare Burden
-
May 27, 2026, 16:00Revealing Critical Gaps in Hemophilia Diagnosis and Access to Care in India – WFH
-
May 27, 2026, 16:00Melissa Hollo: Women Deserve Proactive Care, Not Reactive Care
-
May 27, 2026, 15:59Piotr Czempik: First Report of ROTEM Findings in Triple-Positive APS and Hageman Anomaly